NASDAQ:TNDM Tandem Diabetes Care (TNDM) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free TNDM Stock Alerts $35.41 +0.11 (+0.31%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$35.06▼$36.0950-Day Range$22.09▼$35.4152-Week Range$13.82▼$43.51Volume1.81 million shsAverage Volume1.89 million shsMarket Capitalization$2.32 billionP/E RatioN/ADividend YieldN/APrice Target$36.36 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Tandem Diabetes Care alerts: Email Address Tandem Diabetes Care MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside2.7% Upside$36.36 Price TargetShort InterestBearish12.31% of Shares Sold ShortDividend StrengthN/ASustainability-0.64Upright™ Environmental ScoreNews Sentiment1.11Based on 11 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.62) to ($1.06) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.77 out of 5 starsMedical Sector696th out of 938 stocksSurgical & Medical Instruments Industry71st out of 95 stocks 1.2 Analyst's Opinion Consensus RatingTandem Diabetes Care has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 5 buy ratings, 6 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $36.36, Tandem Diabetes Care has a forecasted upside of 2.7% from its current price of $35.41.Amount of Analyst CoverageTandem Diabetes Care has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted12.31% of the outstanding shares of Tandem Diabetes Care have been sold short.Short Interest Ratio / Days to CoverTandem Diabetes Care has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Tandem Diabetes Care has recently increased by 64.90%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldTandem Diabetes Care does not currently pay a dividend.Dividend GrowthTandem Diabetes Care does not have a long track record of dividend growth. Previous Next 4.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreTandem Diabetes Care has received a 80.42% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Insulin pumps" product. See details.Environmental SustainabilityThe Environmental Impact score for Tandem Diabetes Care is -0.64. Previous Next 3.4 News and Social Media Coverage News SentimentTandem Diabetes Care has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Tandem Diabetes Care this week, compared to 5 articles on an average week.Search Interest11 people have searched for TNDM on MarketBeat in the last 30 days. This is an increase of 38% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Tandem Diabetes Care to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tandem Diabetes Care insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.50% of the stock of Tandem Diabetes Care is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Tandem Diabetes Care are expected to grow in the coming year, from ($1.62) to ($1.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tandem Diabetes Care is -10.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tandem Diabetes Care is -10.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTandem Diabetes Care has a P/B Ratio of 7.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. About Tandem Diabetes Care Stock (NASDAQ:TNDM)Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.Read More TNDM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TNDM Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comTandem Diabetes Care (NASDAQ:TNDM) Upgraded by Stifel Nicolaus to BuyMarch 26, 2024 | fool.comWhy Tandem Diabetes Care Stock Was Zooming Higher TodayMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 26, 2024 | msn.comTandem Diabetes raised to Buy at Stifel on Mobi launchMarch 24, 2024 | americanbankingnews.comTandem Diabetes Care (NASDAQ:TNDM) Trading Down 5%March 22, 2024 | americanbankingnews.comTandem Diabetes Care (NASDAQ:TNDM) Upgraded to "Hold" by StockNews.comMarch 20, 2024 | investorplace.comShhh! 7 Small-Cap Stocks That Can Double by 2025March 20, 2024 | finance.yahoo.comHere are the Reasons to Invest in Tandem Diabetes Care (TNDM)March 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 19, 2024 | americanbankingnews.comTandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $31.00 by Analysts at CitigroupMarch 18, 2024 | finance.yahoo.comParexel Announces CEO Succession PlanMarch 16, 2024 | finance.yahoo.comTNDM Aug 2024 35.000 callMarch 16, 2024 | ca.finance.yahoo.comTNDM Apr 2024 30.000 callMarch 13, 2024 | finance.yahoo.comTandem Diabetes Care (NASDAQ:TNDM) three-year losses have grown faster than shareholder returns have fallen, but the stock soars 10% this past weekMarch 11, 2024 | finance.yahoo.comTandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump HigherMarch 6, 2024 | nasdaq.comTandem Diabetes Care Prices Private Placement Of $275 Mln Of Convertible Senior Notes Due 2029March 6, 2024 | marketwatch.comTandem Diabetes Care Shares Drop 12% After Private Placement for Senior NotesMarch 6, 2024 | businesswire.comTandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029March 6, 2024 | businesswire.comTandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029March 4, 2024 | seekingalpha.comOGI, SFIX and AVAV are among after hour moversMarch 4, 2024 | finance.yahoo.comTandem Diabetes Care Announces Proposed Private Placement of Convertible NotesFebruary 28, 2024 | msn.comTandem Diabetes (NASDAQ:TNDM): Investors Look to Innovation to Drive the Stock HigherFebruary 26, 2024 | markets.businessinsider.comTandem Diabetes Care Holds Steady: A Cautious Outlook Amidst Growth and Competitive UncertaintyFebruary 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Savara (SVRA), Harmony Biosciences Holdings (HRMY) and Tandem Diabetes Care (TNDM)February 22, 2024 | fool.comWhy Tandem Diabetes Care Stock Popped TodayFebruary 22, 2024 | finance.yahoo.comTandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2023 Earnings Call TranscriptFebruary 21, 2024 | finance.yahoo.comTandem Diabetes Care, Inc. (TNDM) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesSee More Headlines Receive TNDM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/21/2024Today3/28/2024Next Earnings (Estimated)5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:TNDM CUSIPN/A CIK1438133 Webwww.tandemdiabetes.com Phone(858) 366-6900FaxN/AEmployees2,400Year Founded2006Price Target and Rating Average Stock Price Target$36.36 High Stock Price Target$62.00 Low Stock Price Target$21.00 Potential Upside/Downside+2.7%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($3.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-222,610,000.00 Net Margins-29.77% Pretax Margin-29.46% Return on Equity-31.48% Return on Assets-10.75% Debt Debt-to-Equity Ratio0.91 Current Ratio3.83 Quick Ratio3.02 Sales & Book Value Annual Sales$747.72 million Price / Sales3.11 Cash FlowN/A Price / Cash FlowN/A Book Value$4.81 per share Price / Book7.36Miscellaneous Outstanding Shares65,630,000Free Float63,990,000Market Cap$2.32 billion OptionableOptionable Beta1.08 Social Links 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. John F. Sheridan (Age 69)President, CEO & Director Comp: $1.23MMs. Leigh A. Vosseller (Age 50)Executive VP, CFO & Treasurer Comp: $665.43kMs. Susan M. Morrison (Age 45)Executive VP & Chief Administrative Officer Comp: $674.76kMr. David B. Berger Esq. (Age 54)Transitional Advisor Comp: $670.18kMr. Brian B. Hansen (Age 56)Executive Officer Comp: $650.19kMs. Elizabeth Anne Gasser (Age 48)Executive Vice President and Chief Strategy & Product Officer Comp: $606.83kMr. Rick A. Carpenter (Age 61)Chief Technical Officer Ms. Shannon M. Hansen (Age 58)Chief Legal, Privacy & Compliance Officer and Secretary Mr. Tom FoxChief Human Resources OfficerDr. Jordan Pinsker M.D.Chief Medical OfficerMore ExecutivesKey CompetitorsPROCEPT BioRoboticsNASDAQ:PRCTICU MedicalNASDAQ:ICUIAlphatecNASDAQ:ATECIntegra LifeSciencesNASDAQ:IARTInari MedicalNASDAQ:NARIView All CompetitorsInsiders & InstitutionsNewbridge Financial Services Group Inc.Sold 1,555 shares on 3/28/2024Ownership: 0.007%PNC Financial Services Group Inc.Bought 2,562 shares on 3/22/2024Ownership: 0.009%Kingdon Capital Management L.L.C.Bought 194,200 shares on 3/18/2024Ownership: 0.296%Vanguard Group Inc.Bought 18,571 shares on 3/11/2024Ownership: 10.699%Price T Rowe Associates Inc. MDBought 1,931 shares on 2/16/2024Ownership: 0.056%View All Insider TransactionsView All Institutional Transactions TNDM Stock Analysis - Frequently Asked Questions Should I buy or sell Tandem Diabetes Care stock right now? 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tandem Diabetes Care in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TNDM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TNDM, but not buy additional shares or sell existing shares. View TNDM analyst ratings or view top-rated stocks. What is Tandem Diabetes Care's stock price target for 2024? 12 Wall Street analysts have issued 1-year price targets for Tandem Diabetes Care's stock. Their TNDM share price targets range from $21.00 to $62.00. On average, they predict the company's stock price to reach $36.36 in the next twelve months. This suggests a possible upside of 2.7% from the stock's current price. View analysts price targets for TNDM or view top-rated stocks among Wall Street analysts. How have TNDM shares performed in 2024? Tandem Diabetes Care's stock was trading at $29.58 at the beginning of the year. Since then, TNDM shares have increased by 19.7% and is now trading at $35.41. View the best growth stocks for 2024 here. Are investors shorting Tandem Diabetes Care? Tandem Diabetes Care saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 8,080,000 shares, an increase of 64.9% from the February 29th total of 4,900,000 shares. Based on an average daily volume of 1,800,000 shares, the short-interest ratio is presently 4.5 days. View Tandem Diabetes Care's Short Interest. When is Tandem Diabetes Care's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our TNDM earnings forecast. How were Tandem Diabetes Care's earnings last quarter? Tandem Diabetes Care, Inc. (NASDAQ:TNDM) released its quarterly earnings results on Wednesday, February, 21st. The medical device company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.23) by $0.04. The medical device company had revenue of $196.80 million for the quarter, compared to analysts' expectations of $204.86 million. Tandem Diabetes Care had a negative net margin of 29.77% and a negative trailing twelve-month return on equity of 31.48%. What ETFs hold Tandem Diabetes Care's stock? ETFs with the largest weight of Tandem Diabetes Care (NASDAQ:TNDM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Harbor Corporate Culture Small Cap ETF (HAPS), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Syntax Stratified SmallCap ETF (SSLY).iShares U.S. Medical Devices ETF (IHI). When did Tandem Diabetes Care's stock split? Shares of Tandem Diabetes Care reverse split before market open on Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What guidance has Tandem Diabetes Care issued on next quarter's earnings? Tandem Diabetes Care updated its first quarter 2024 earnings guidance on Wednesday, February, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $175.0 million-$175.0 million, compared to the consensus revenue estimate of $186.1 million. What is John Sheridan's approval rating as Tandem Diabetes Care's CEO? 11 employees have rated Tandem Diabetes Care Chief Executive Officer John Sheridan on Glassdoor.com. John Sheridan has an approval rating of 88% among the company's employees. What other stocks do shareholders of Tandem Diabetes Care own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tandem Diabetes Care investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Micron Technology (MU), DexCom (DXCM), Netflix (NFLX), Block (SQ), Roku (ROKU), Lululemon Athletica (LULU) and PayPal (PYPL). Who are Tandem Diabetes Care's major shareholders? Tandem Diabetes Care's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.77%), Vanguard Group Inc. (10.70%), Capital World Investors (9.79%), Eminence Capital LP (7.93%), Bellevue Group AG (3.06%) and Jennison Associates LLC (1.98%). Insiders that own company stock include Brian B Hansen, Christopher J Twomey, Christopher J Twomey, David B Berger, Dick Allen, Elizabeth Anne Gasser, James Leal, John F Sheridan, Kathleen Mcgroddy-Goetz, Kim D Blickenstaff, Leigh Vosseller, Mark Reinstra, Rebecca B Robertson, Rebecca B Robertson, Shannon Marie Hansen and Susan Morrison. View institutional ownership trends. How do I buy shares of Tandem Diabetes Care? Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TNDM) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.